CDXC (ChromaDex Corp) Gross Margin

Corporate emblem and logo of ChromaDex (CDXC)

ChromaDex Corporation leverages trust in Tru Niagen to establish itself as an expert in cellular regeneration. The gross margin on this chart demonstrates the business's adaptability, with the parameter value equal to 61.80. Efficient global supply chains minimize delivery costs for supplements. High profitability is underpinned by an exclusive patent for NR synthesis, which blocks competitors' access to the formula.

CDXC - chromadex.com Gross Margin over the range 07/04/2022 - 03/19/2025

Comprehensive metric breakdowns and analytics for ChromaDex Corp (CDXC)

- business market valuation indicators:
Fundamental valuation:CDXC, chromadex.com
Brand item of ChromaDex Corp.

Gross margin measures production efficiency by determining the profit share after deducting direct costs of goods sold. By analyzing gross margin profitability, an investor can track operational cost dynamics and the business's ability to maintain pricing power. The metric's high sensitivity to cost of sales confirms the value of the Niagen patents, providing ChromaDex Corporation (CDXC) with premium positioning in the science-based longevity supplement segment.